us.cnn.com
🌐 75% Global Worthiness
FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
Progress
32% Bias Score
Good Health and Well-being